Quarterly ResultJul 28, 2026, 04:08 PM
Jushi Q2 Revenue $71.3M (+10%); Net Loss $7.3M; Tax Benefit $6.4M
AI Summary
Jushi Holdings Inc. reported Q2 2026 financial results with revenue increasing 10% year-over-year to $71.3 million, driven by strong wholesale growth of 68% to $9.4 million. The company posted a net loss of $7.3 million, an improvement from the prior year, and an Adjusted EBITDA of $13.3 million. Key strategic developments include a $6.4 million income tax benefit from medical marijuana rescheduling and the enactment of adult-use cannabis legislation in Virginia, set to begin sales in July 2027.
Key Highlights
- Revenue increased 10% year-over-year to $71.3 million.
- Wholesale revenue grew 68% to an all-time quarterly record of $9.4 million.
- Reported a net loss of $7.3 million, an improvement from $12.3 million loss in Q2 2025.
- Adjusted EBITDA was $13.3 million with an 18.7% margin.
- Recognized a $6.4 million income tax benefit due to medical marijuana rescheduling to Schedule III.
- Virginia enacted legislation for adult-use cannabis sales commencing July 1, 2027.
- Cash, cash equivalents, and restricted cash totaled $35.5 million as of quarter-end.
- Shareholders approved continuance from British Columbia to Nevada to align corporate structure.
Price Impact
More from JUSHF